Imperial College London

Dr. Nimalan Arinaminpathy (Nim Pathy)

Faculty of MedicineSchool of Public Health

Senior Lecturer in Population Biology
 
 
 
//

Contact

 

nim.pathy Website

 
 
//

Location

 

Praed StreetSt Mary's Campus

//

Summary

 

Summary

I am a Senior Lecturer in the Department of Infectious Disease Epiemiology, in the School of Public Health, at Imperial College London. I apply mathematical and statistical tools to study the transmission dynamics of infectious diseases, with equal interest in basic science and policy-focused analysis. 

Research interests

A major focus of my research is in the interface between health/economic systems and infectious diseases, particularly in the context of human tuberculosis. This includes understanding how health systems shape the control of infectious diseases (with the Public Health Foundation of India), and studying financing mechanisms for the supply of drugs to countries in need (with the Stop TB Partnership).

I am periodically seconded to the US Centers for Disease Control and Prevention, where I apply mathematical modelling to the surveillance and control of seasonal and pandemic influenza, amongst other topics.

More broadly, events in global financial markets since 2007 have heightened interest in applying insights from other systems, including infectious disease epidemiology, to understanding the spread and control of 'contagion' in modern financial systems. With colleagues from the Bank of England and the University of Oxford, I maintain a continuing involvement in this area.   

Biographical sketch

I trained in Applied Mathematics (BA Cambridge 2000, D.Phil Oxford 2005); between these programmes I spent a year as a scientist in a government research lab (Dstl, 2001). 

Following my DPhil I trained in mathematical epidemiology as a postdoctoral researcher, first at the University of Oxford and then at Princeton University (USA) before finally returning to the UK.

Publications

Journals

Arinaminpathy N, Batra D, Khaparde S, et al., 2016, The number of privately treated tuberculosis cases in India: an estimation from drug sales data, Lancet Infectious Diseases, Vol:16, ISSN:1473-3099, Pages:1255-1260

Hastings DL, Tokars JI, Aziz IZAMA, et al., 2016, Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014, Emerging Infectious Diseases, Vol:22, ISSN:1080-6040, Pages:794-801

Houben RM, Menzies NA, Sumner T, et al., 2016, Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models., Lancet Glob Health, Vol:4, Pages:e806-e815

Menzies NA, Gomez GB, Bozzani F, et al., 2016, Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models., Lancet Glob Health, Vol:4, Pages:e816-e826

Nair SA, Raizada N, Sachdeva KS, et al., 2016, Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis, Plos One, Vol:11, ISSN:1932-6203

More Publications